Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

RNACRNAC
5 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CARTESIAN THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 80,572 shares of RNAC (CARTESIAN THERAPEUTICS INC), worth $839,560 as of 2026-Q2. The position was increased (+160.5% shares). RNAC represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$839,560

Current Shares

80,572

Total Value Change

+$346,587

Total Shares Change

+53,047

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
80,572
+160.5%
$839,5600.0%$10.42
40
2026-Q1
New
30,927
-
$190,2010.0%$7.48
35
2025-Q2
Exited
0
-100.0%
$00.0%$10.68
0
2025-Q1
Decreased
15,775
-42.7%
$207,9150.0%$14.54
0
2024-Q4
New
27,525
-
$492,9730.0%$18.76
33

Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used